GSK Consumer Healthcare Q4 profit up 35 percent to Rs 285 crore

In a separate filing, GSK Consumer Healthcare informed that its board has recommended a dividend at the rate of Rs 105 per equity share of Rs 10 each.

New Delhi: Glaxo Smith Kline (GSK) Consumer Healthcare on Friday reported 34.93 per cent increase in standalone net profit at Rs 285.81 crore for the fourth quarter ended March 31, 2019.

The company clocked a profit of Rs 211.81 crore in the January-March quarter a year ago, it said in a BSE filing.

Read Also: GSK expects shingles drug sales to exceed $1.3 billion

Total income in the latest quarter was up 11.48 per cent to Rs 1,408.95 crore as against Rs 1,263.75 crore in the year-ago period.

Total expenses in the March quarter 2019 were Rs 982.70 crore, up 4 per cent from Rs 944.86 crore in the year-ago period.

For 2018-19, the company registered a profit of Rs 982.80 crore, a rise of 40.37 per cent from Rs 700.10 crore logged in 2017-18.

Read Also: GSK gets USFDA nod for HIV-1 drug branded as Dovato

Total income during 2018-19 stood at Rs 5,214.61 crore as against Rs 4,634.46 crore in the previous year.

In a separate filing, GSK Consumer Healthcare informed that its board has recommended a dividend at the rate of Rs 105 per equity share of Rs 10 each.

Shares of the company settled at Rs 7,035.85 per scrip on BSE, down 0.70 per cent from the previous close.

Read Also: HUL expects to complete merger with GSK Consumer Healthcare in 2019